Five years ago, on March 11, the World Health Organization declared COVID-19 a global pandemic. The vaccines “underwent the most intensive safety analysis in U.S. history." ...
The rivalry between Moderna and Pfizer/BioNTech ... the potentially lucrative opportunity for booster shots targeting new variants like Omicron as COVID-19 becomes endemic. It's not the first ...
“The companies told the PTAB in the petitions that Moderna’s patents include ‘unimaginably broad claims directed to a basic idea.’” Patent Trial and Appeal Board (PTAB) docket entries ...
[What you need to know about the Moderna and Pfizer coronavirus vaccines] Researchers ... making this approach potentially less useful if booster shots need to be given. Viral-vectored vaccines ...
Dr. Marty Makary, President Donald Trump's choice to lead the Food and Drug Administration, pointed out the Biden ...
The Iowa Senate bill alters a proposal that would have penalized administering gene-based vaccines including the COVID-19 ...
March 5 - Pfizer (PFE.N), opens new tab and BioNTech (22UAy.DE), opens new tab won a round in their legal battle with Moderna (MRNA.O), opens new tab over COVID-19 vaccine patents on Wednesday ...
It has been five years since the World Health Organisation (WHO) declared COVID-19 a pandemic in March 2020 a decision that ...
“Many didn’t get a COVID booster,” he said ... community in Massachusetts. Moderna, a Cambridge biotech, fielded one of the two messenger RNA vaccines and now has a crop of new vaccines ...
Three-member expert panel will oversee process to dispose of the Sinovac-CoronaVac doses that expired in December 2023.
The Patent Trial and Appeal Board agreed with Pfizer and its German partner that Moderna's patents were invalid based on "prior art" that disclosed the inventions before Moderna patented them. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results